UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002

2021

Volltextzugriff (PDF)

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

The New England journal of medicine, 2010-09, Vol.363 (10), p.905-917

2010

Volltextzugriff (PDF)

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

The Lancet (British edition), 2005-04, Vol.365 (9468), p.1389-1397

2005

Volltextzugriff (PDF)

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

Diabetes, obesity & metabolism, 2022-08, Vol.24 (8), p.1553-1564

2022

Volltextzugriff (PDF)

Evaluation of a Role for NPY and NPY2R in the Pathogenesis of Obesity by Mutation and Copy Number Variation Analysis in Obese Children and Adolescents

Annals of human genetics, 2018-01, Vol.82 (1), p.1-10

2018

Volltextzugriff (PDF)

Mechanisms linking obesity with cardiovascular disease

Nature, 2006-12, Vol.444 (7121), p.875-880

2006

Volltextzugriff (PDF)

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

The Lancet (British edition), 2006-11, Vol.368 (9548), p.1660-1672

2006

Volltextzugriff (PDF)

Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes

Diabetes, obesity & metabolism, 2022-05, Vol.24 (5), p.788-805

2022

Volltextzugriff (PDF)

Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients

Diabetes care, 2005-07, Vol.28 (7), p.1649-1655

2005

Volltextzugriff (PDF)

Sleep-Disordered Breathing, Obesity, and Airway Inflammation in Children and Adolescents

Chest, 2008-12, Vol.134 (6), p.1169-1175

2008

Volltextzugriff (PDF)

Overweight, obesity, and outcomes: fat mass and beyond

The Lancet (British edition), 2014-03, Vol.383 (9921), p.935-936

2014

Volltextzugriff (PDF)

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

Annals of internal medicine, 2005-10, Vol.143 (8), p.559

2005

Volltextzugriff (PDF)

751-P: Effect Of Once-Weekly Semaglutide on Weight Change and Metabolic Control in People with Type 1 Diabetes—Six-Months Results from the Real-World STEMT Trial

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Exposure to Persistent Organic Pollutants: Relationship With Abnormal Glucose Metabolism and Visceral Adiposity

Diabetes care, 2014-07, Vol.37 (7), p.1951-1958

2014

Volltextzugriff (PDF)

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study

European heart journal, 2008-07, Vol.29 (14), p.1761-1771

2008

Volltextzugriff (PDF)

Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review

The journal of clinical endocrinology and metabolism, 2008-02, Vol.93 (2), p.363-371

2008

Volltextzugriff (PDF)

Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish

The American journal of clinical nutrition, 2016-04, Vol.103 (4), p.989-998

2016

Volltextzugriff (PDF)

Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)

The American journal of clinical nutrition, 2003-08, Vol.78 (2), p.209-214

2003

Volltextzugriff (PDF)

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

The Lancet (British edition), 2000-12, Vol.356 (9248), p.2119-2125

2000

Volltextzugriff (PDF)

Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?

European journal of endocrinology, 2008-06, Vol.158 (6), p.773-784

2008

Volltextzugriff (PDF)

Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: Histological and clinical findings

Diabetes care, 2003, Vol.26 (1), p.82-88

2003

Volltextzugriff (PDF)

Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders

The American journal of clinical nutrition, 2005-07, Vol.82 (1), p.21-25

2005

Volltextzugriff (PDF)

Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes

Diabetes care, 2002-05, Vol.25 (5), p.912-917

2002

Volltextzugriff (PDF)

Identification and functional characterization of a missense mutation in resistin in two patients with severe obesity and insulin resistance

European journal of endocrinology, 2011-06, Vol.164 (6), p.927-936

2011

Volltextzugriff (PDF)

Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes: A substudy of the SCOUT trial

Diabetes care, 2013-11, Vol.36 (11), p.3746-3753

2013

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(94)

Sprache

Englisch
(92)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Science & Technology
(64)
Life Sciences & Biomedicine
(63)
Female
(50)
Male
(47)
Obesity
(39)
Middle Aged
(35)
Diabetes
(33)
Adult
(31)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Endocrinology & Metabolism
(28)
Adolescent
(20)
Risk Factors
(20)
Aged
(19)
Body Mass Index
(18)
Endocrinopathies
(16)
Diabetes. Impaired Glucose Tolerance
(15)
Endocrine Pancreas. Apud Cells
(15)
Double-Blind Method
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

Evaluation of a Role for NPY and NPY2R in the Pathogenesis of Obesity by Mutation and Copy Number Variation Analysis in Obese Children and Adolescents

Mechanisms linking obesity with cardiovascular disease

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes

Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients

Sleep-Disordered Breathing, Obesity, and Airway Inflammation in Children and Adolescents

Overweight, obesity, and outcomes: fat mass and beyond

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

751-P: Effect Of Once-Weekly Semaglutide on Weight Change and Metabolic Control in People with Type 1 Diabetes—Six-Months Results from the Real-World STEMT Trial

Exposure to Persistent Organic Pollutants: Relationship With Abnormal Glucose Metabolism and Visceral Adiposity

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study

Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review

Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish

Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?

Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: Histological and clinical findings

Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders

Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes

Identification and functional characterization of a missense mutation in resistin in two patients with severe obesity and insulin resistance

Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes: A substudy of the SCOUT trial

Aktive Filter

Suchergebnisse filtern